Cholangiocarcinoma

被引:1103
作者
Khan, SA
Thomas, HC
Davidson, BR
Taylor-Robinson, SD
机构
[1] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Med, Liver Unit, London, England
[2] Royal Free Hosp, Dept Surg, London NW3 2QG, England
关键词
D O I
10.1016/S0140-6736(05)67530-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cholangiocarcinoma is a devastating malignancy that presents late, is notoriously difficult to diagnose, and is associated with a high mortality. The incidence of intrahepatic cholangiocarcinoma is increasing worldwide. The cause for this rise is unclear, although it could be related to an interplay between predisposing genetic factors and environmental triggers. MRI and CT with endoscopic ultrasound and PET provide useful diagnostic information in certain patients. Surgical resection is the only chance for cure, with results depending on careful technique and patient selection. Data suggest that liver transplantation could offer long-term survival in selected patients when combined with neoadjuvant chemoradiotherapy. Chemotherapy and radiotherapy have been ineffective for patients with inoperable tumours. For most of these patients biliary drainage is the mainstay of palliation. However, controversy exists over the type and positioning of biliary stents. Photodynamic treatment is a new palliative technique that might improve quality of life.
引用
收藏
页码:1303 / 1314
页数:12
相关论文
共 129 条
  • [1] Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization
    Abdalla, EK
    Barnett, CC
    Doherty, D
    Curley, SA
    Vauthey, JN
    [J]. ARCHIVES OF SURGERY, 2002, 137 (06) : 675 - 680
  • [2] Endoscopic management of cholangiocarcinoma
    Abu-Hamda, EM
    Baron, TH
    [J]. SEMINARS IN LIVER DISEASE, 2004, 24 (02) : 165 - 175
  • [3] c-erbB-2 and c-Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma
    Aishima, SI
    Taguchi, KI
    Sugimachi, K
    Shimada, M
    Sugimachi, K
    Tsuneyoshi, M
    [J]. HISTOPATHOLOGY, 2002, 40 (03) : 269 - 278
  • [4] ELEVATED SERUM LEVELS OF TUMOR-MARKER CA19-9 IN ACUTE CHOLANGITIS
    ALBERT, MB
    STEINBERG, WM
    HENRY, JP
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1988, 33 (10) : 1223 - 1225
  • [5] Diagnosis and treatment of cholangiocarcinoma
    Anderson, CD
    Pinson, CW
    Berlin, J
    Chari, RS
    [J]. ONCOLOGIST, 2004, 9 (01) : 43 - 57
  • [6] Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma
    Anderson, CD
    Rice, MH
    Pinson, W
    Chapman, WC
    Chari, RS
    Delbeke, D
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2004, 8 (01) : 90 - 97
  • [7] A Prospective Comparison of Digital Image Analysis and Routine Cytology for the Identification of Malignancy in Biliary Tract Strictures
    Baron, Todd H.
    Harewood, Gavin C.
    Rumalla, Ashwin
    Pochron, Nicole L.
    Stadheim, Linda M.
    Gores, Gregory J.
    Therneau, Terry M.
    De Groen, Piet C.
    Sebo, Thomas J.
    Salomao, Diva R.
    Kipp, Benjamin R.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (03) : 214 - 219
  • [8] Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis:: A case-control study
    Bergquist, A
    Glaumann, H
    Persson, B
    Broomé, U
    [J]. HEPATOLOGY, 1998, 27 (02) : 311 - 316
  • [9] Photodynamic therapy for cholangiocarcinoma
    Berr, F
    [J]. SEMINARS IN LIVER DISEASE, 2004, 24 (02) : 177 - 187
  • [10] The molecular pathogenesis of cholangiocarcinoma
    Berthiaume, EP
    Wands, J
    [J]. SEMINARS IN LIVER DISEASE, 2004, 24 (02) : 127 - 137